Results 231 to 240 of about 54,010 (241)

Irinotecan

Reactions Weekly, 2017
  +4 more sources

Clinical and pharmacogenetic factors associated with irinotecan toxicity

Cancer Treatment Reviews, 2008
Henk-Jan Guchelaar, Hans Gelderblom
exaly  

Hyaluronan-Irinotecan improves progression-free survival in 5-fluorouracil refractory patients with metastatic colorectal cancer: a randomized phase II trial

Cancer Chemotherapy and Pharmacology, 2010
Peter Gibbs, Craig Underhill, Tracey J Brown   +2 more
exaly  

Irinotecan

Reactions Weekly, 2015
openaire   +1 more source

Efficacy of FOLFIRI-3 (irinotecan D1,D3 combined with LV5-FU) or other irinotecan-based regimens in oxaliplatin-pretreated metastatic colorectal cancer in the GERCOR OPTIMOX1 study

Annals of Oncology, 2009
C Tournigand, M Mabro, A Figer
exaly  

Irinotecan

Reactions Weekly, 2018
openaire   +1 more source

Irinotecan

Reactions Weekly
openaire   +2 more sources

Clinical Pharmacokinetics of Irinotecan

Clinical Pharmacokinetics, 2012
Guy G Chabot
exaly  

Irinotecan

Reactions Weekly, 2008
openaire   +1 more source

Irinotecan

2007
openaire   +1 more source